Atorvastatin prevents left ventricular remodeling in spontaneously hypertensive rats

International Heart Journal

Volumn 51, Issue 6, 2010, Pages 426-431

  Zhao, Xiao yan ^a   Li, Ling ^a   Zhang, Jin ying ^a   Liu, Gang qiong ^a   Chen, Ya li ^a   Yang, Pei ling ^a   Liu, Rui yun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Atorvastatin; Connective tissue growth factor; Left ventricular remodeling; Spontaneously hypertensive rats

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; GENE EXPRESSION; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PYRROLES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VENTRICULAR REMODELING;

EID: 78650597825     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.426     Document Type: Article

References (31)

1. Ishikawa Y. High blood pressure and cardiac hypertrophy. Nippon Rinsho 2004; 62: 342-346. (Review) (Japanese)
2. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 1998; 76: 725-46. (Review)
3. Buemi M, Corica F, Marino D, et al. Cardiovascular remodeling, apoptosis, and drugs. Am J Hypertens 2000; 13: 450-454. (Review)
4. Louhelainen M, Vahtola E, Kaheinen P, et al. Effects of levosi-mendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. Br J Pharmacol 2007; 150: 851-861.
5. Sakairi A, Ishida J, Honjo K, et al. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension. Hypertens Res 2008; 31: 2165-2175.
6. Kang L, Ge CJ, Hu SJ. Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats. Pharmacology 2007; 80: 120-126.
7. Li G, Li D, Xie Q, Shi Y, Jiang S, Jin Y. RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production. J Gene Med 2008; 10: 1039-1047.
8. Riser BL, Najmabadi F, Perbal B, et al. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 2009; 174: 1725-1734.
9. Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of micro RNAs in myocardial matrix remodeling. Circ Res 2009; 104: 170-8.
10. Wang B, Haldar SM, Lu Y, et al. The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol 2008; 45: 193-7.
11. Iwanciw D, Rehm M, Porst M, Goppelt-Struebe M. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arterioscler Thromb Vasc Biol 2003; 23: 1782-7.
12. Rupérez M, Rodrigues-Díez R, Blanco-Colio LM, et al. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Hypertension 2007; 50: 377-83.
13. Martin J, Denver R, Bailey M, Krum H. In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling. Clin Exp Pharmacol Physiol 2005; 32: 697-701.
14. Geng J, Zhao Z, Kang W, Wang W, Zhang Y, Zhiming GE. Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats. Pharmacol Res 2010; 61: 40-7.
15. Ge CJ, Lu SZ, Chen YD, Wu XF, Hu SJ, Ji Y. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. Heart Vessels 2008; 23: 91-5.
16. Kang L, Hu SJ. Effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats. Zhejiang Da Xue Xue Bao Yi Xue Ban 2007; 36: 54-60. (Chinese)
17. Zhao XY, Hu SJ, Li J, et al. rAAV-mediated angiogenin gene transfer induces angiogenesis and modifies left ventricular remodeling in rats with myocardial infarction. J Mol Med 2006; 84: 1033-46.
18. Czarnowska E, Gajerska-Dzieciatkowska M, Kuśmierski K, et al. Expression of SDF-1-CXCR4 axis and an anti-remodelling effectiveness of foetal-liver stem cell transplantation in the infrarcted rat heart. J Physiol Pharmacol 2007; 58: 729-44.
19. Lal A, Veinot J P, Ganten D, Leenen FH. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol 2005; 39: 521-9.
20. Kytö V, Saraste A, Saukko P, et al. Apoptotic cardiomyocyte death in fatal myocarditis. Am J Cardiol 2004; 94: 746-50.
21. Poelmann RE, Gittenberger-de Groot AC. Apoptosis as an instrument in cardiovascular development. Birth Defects Res C Embryo Today 2005; 75: 305-313. (Review)
22. Anselmi A, Lotrionte M, Biondi-Zoccai GG, Galiuto L, Abbate A. Left ventricular hypertrophy, apoptosis, and progression to heart failure in severe aortic stenosis. Eur Heart J 2005; 26: 2747.
23. Hamet P, Richard L, Dam T V, et al. Apoptosis in target organs of hypertension. Hypertension 1995; 26: 642-8.
24. Hamet P, Moreau P, Dam TV, et al. The time window of apopto-sis: a new component therapeutic strategy for cardiovascular remodeling. J Hypertens Suppl 1996; 14: S65-70. (Review)
25. Li FQ, Chen YZ. Changes and significance of cardiac myocyte apoptosis in spontaneously hypertensive rat. Chin J Cardiol 1999; 27: 459-63.
26. Ikeda S, Hamada M, Qu P, et al. Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodeling in Dahl rats. Clin Sci (Lond) 2002; 102: 329-35.
27. Ogata Y, Takahashi M, Takeuchi K, et al. Fluvastatin induces ap-optosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy. J Cardiovasc Pharmacol 2002; 40: 907-15.
28. Che ZQ, Gao PJ, Shen WL, Fan CL, Liu JJ, Zhu DL. Angiotensin II-stimulated collagen synthesis in aortic adventitial fbroblasts is mediated by connective tissue growth factor. Hypertens Res 2008; 31: 1233-40.
29. Bai Y P, Liu CH, Yang L, Liu WJ. Correlation between connective tissue growth factor and fibrosis of myocardium in spontaneously hypertensive rats and intervention with irbesartan. Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2006; 8: 47-50.
30. Sarafdis PA, Kanaki AI, Lasaridis AN. Effects of statins on blood pressure: a review of the experimental and clinical evidence. Curr Vasc Pharmacol 2007; 5: 155-161. (Review)
31. Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH. Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med 2008; 168: 721-727.